Login
mo_101317152.jpg

Investors

OrthoPediatrics currently markets greater than 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and nearly 40 countries outside the United States.

Investors

Change (%)
Volume
Data as of

Copyright West LLC. Minimum 15 minutes delayed.

Recent News Releases
Aug 19, 2019
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for First Pediatric-Specific Foot System
WARSAW, Ind. , Aug. 19, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration ( FDA ) for its new
Aug 07, 2019
OrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results
Record revenue of $18.2 Million, Up 20.7% Year-over-Year WARSAW, Ind. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the quarter
Aug 05, 2019
OrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference
WARSAW, Ind. , Aug. 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl , President & Chief Executive Officer, and Fred Hite , Chief Financial
Upcoming/Recent Events
More events are coming soon.
learn more

Contact IR

Primary IR Contact
Tram Bui
The Ruth Group
Phone: (646) 536-7035
E-mail: tbui@theruthgroup.com

learn more

Investor Faq

Find answers to frequently asked questions.

learn more